Colgate Palmolive (India) Limited — Q4 FY26 earnings call

Call held 28 May 2026

Management summary

Colgate-Palmolive (India) Limited reported a strong Q4 FY26 with accelerated net sales growth of 9% and domestic growth of 9.2%, driven by premiumization and core brand strength. Gross and EBITDA margins remained robust, with Q4 NPAT at ₹353 crores. While the full year saw flat top-line growth, the company is optimistic about future growth, focusing on balanced volume and pricing, and addressing challenges like the GST IDS impact and high promotional intensity.

Highlights

  • Net sales growth for Q4 accelerated to 9% year-on-year, reaching ₹1,583 crores.

  • Domestic growth for Q4 was strong at 9.2%.

  • Gross margins remained resilient at 69.6% for Q4 and 69.3% for the full year.

  • EBITDA margins were best-in-class at over 32% for Q4 and 31.2% for the full year.

  • NPAT for Q4 was ₹353 crores, growing in line with the overall top line (excluding one-off).

  • Cash-in was ₹1,806 crores, which was better than prior years.

  • Return on capital employed was at a very high level of 121%.

  • Premiumization mix is up 35% over the past two years, with premium segment growth accelerating to six times the toothpaste category growth.

  • E-commerce channel now constitutes roughly 10% of the business, growing faster, gaining share, and driving premiumization and margin.

Concerns

  • Overall full year top-line growth was flat due to tough quarters in the previous calendar year, leading to slightly challenged full year profitability.

  • The GST IDS impact reduced full year EBITDA margin by 80 basis points and Q4 EBITDA margin by 160 basis points.

  • The market continues to be quite competitive, and promotional intensity is not letting up.

  • Management noted headwinds in terms of commodities and currency for the next two quarters.

Key financials

2 periods

Headline

  • Net Sales (FY)
    ₹5,984 Cr
    YoY 0%
  • Gross Margin (FY)
    69.3%
  • EBITDA Margin (FY)
    31.2%
  • Advertising (FY)
    13.7%
  • Cash-in (FY)
    ₹1,806 Cr
  • Return on Capital Employed (FY)
    121%

Q4

  • Net Sales
    ₹1,583 Cr
    YoY +9%
  • Domestic Growth
    —
    YoY +9.2%
  • Gross Margin
    69.6%
  • EBITDA Margin
    32%
  • NPAT
    ₹353 Cr

What they filed

Q1 FY27: revenue up 11.8%, net profit up 6.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue1,619 1,462 1,463 1,434 1,520 −6%1,486 +2%1,595 +9%1,603 +12%
EBITDA497 454 498 453 465 −6%442 −3%510 +2%483 +7%
Net profit395 323 355 321 328 −17%324 +0%353 −1%343 +7%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Capital allocation

high confidence
  • Dividend ₹48/share (interim) Payout ratio 100%
    Our return on capital employed continues to be at very high levels, 121%. And we have today declared the second interim dividend, which takes it to about RS. 48, and follows our strategy of paying out virtually 100% of the NPAT as dividend.
  • Liquidity Cash ₹1,806 Cr Cash-in was better than prior years.
    So, despite the profitability challenges and the working capital blocked in GST last year, our cash-in was much better than the prior years, as you see, Rs. 1,806 crores.

Guidance & targets

Profitability

  • EBITDA Margin Profitability · next two quarters · Medium confidence 30-32%
    And the margin range you mentioned would be around 30-32% over the next two quarters. Would that be a fair understanding?

    — M.S. Jacob

  • Gross Margin Profitability · ongoing · High confidence in the range
    The gross margin will continue to be in the range.

    — M.S. Jacob

Pricing

  • Pricing Growth Pricing · next few weeks · Medium confidence low single digit
    But it will be in the low single digit.

    — M.S. Jacob

Volume Growth

  • Overall Volume Growth Volume Growth · going forward · High confidence balanced growth between volume and pricing
    Our endeavor is to deliver a balanced growth between volume and pricing. So, similar to what we saw in Q4, that's the kind of volume we are looking at going forward to, and not relying on pricing as much as we have probably done in the past. But also, not relying too much on volume like we have done for a couple of years. So, a balance between the two is what we are seeking to deliver.

    — M.S. Jacob

  • Mid-single-digit volume growth Volume Growth · next few years · Medium confidence fair growth outlook
    is it fair to assume that there's a fair bit of comfort that earlier we used to target and talk about a mid-single-digit volume growth in the business? And is that something that you think is a fair growth outlook for your business for the next few years?

    — Prabha Narasimhan

What to watch in Q1 FY27

EBITDA Margin

next two quarters
Current 32% (Q4 FY26), 31.2% (FY26)
Target 30-32% range

Why it matters

To verify if the company can maintain its industry-leading margins amidst advertising investments and cost headwinds.

And the margin range you mentioned would be around 30-32% over the next two quarters.

Risks & concerns

  • Input cost inflation and currency challenges

    medium

    Management noted 'headwinds of commodity and currency' impacting margins for the next two quarters.

    Management acknowledged

  • GST Inverted Duty Structure (IDS) impact

    medium

    The IDS resulted in an 80bps impact on full-year EBITDA margin and 160bps on Q4 EBITDA margin, with management actively seeking solutions.

    Management acknowledged

  • High promotional intensity in the market

    medium

    The market remains competitive, and management expects promotional intensity to continue at current levels in the short term.

    Management acknowledged

Q&A highlights

7 direct
Impact of QR code dentist connection project on premiumization and B2B sales Direct
We spent significant money behind it and got four and a half million people in India to take the scan. Our estimate is about 20% of those consumers actually went to the dentist. Almost a million people went to the dentist... We grow on average over a two-year CAGR of close to 50-60%. We have feet on the street now of about a shade over 150 people, and we do intend to augment that field force.

Highlights the success and scale of a key consumer engagement and premiumization initiative, and the rapid growth of B2B sales to dental professionals.

Asked by Abneesh Roy

Competition for Visible White Toothpaste and threat from D2C companies Direct
But what we are seeing is that the segment is expanding quite dramatically, and we continue to be the absolute, like massively lion's share of that segment... From a D2C perspective, most of the D2Cs currently are still small. So, are we seeing any share loss? No. In fact, our digital share continues to actually improve, and our shares in Quick Commerce actually tend to be ahead of our shares in the rest of e-commerce, and overall e-commerce tends to be ahead of our overall business.

Addresses competitive landscape and emerging D2C threats, indicating Colgate's continued dominance in the whitening segment and strong performance in digital channels.

Asked by Abneesh Roy

Pricing growth, inflation outlook, and margin guidance for upcoming quarters Direct
So, the pricing that you are seeing, so first of all, the growth is balanced between pricing and volume. It's almost halfway. And all the pricing is the pricing we have taken after the Q1 calendar last year. So, this is just anniversary pricing... We have visibility into the next two quarters. And we believe margins will be in the range. There are some headwinds in terms of commodities and also the currency coming through... And the margin range you mentioned would be around 30-32% over the next two quarters.

Clarifies the nature of Q4 pricing, acknowledges inflationary pressures, and provides specific EBITDA margin guidance for the near term, while noting gross margins will remain stable.

Asked by Mihir Shah

Volume growth trajectory going forward given flat base quarters Direct
Our endeavor is to deliver a balanced growth between volume and pricing. So, similar to what we saw in Q4, that's the kind of volume we are looking at going forward to, and not relying on pricing as much as we have probably done in the past. But also, not relying too much on volume like we have done for a couple of years. So, a balance between the two is what we are seeking to deliver.

Outlines management's strategy for future growth, emphasizing a balanced approach between volume and pricing, moving away from over-reliance on either.

Asked by Mihir Shah

Definition and contribution of 'premium' segment to overall sales Partial
So, we define premium as anything that is over the 130-140 price index to our base and really in brand terms, that is outside of Colgate Active Salt, Max Fresh, Strong Teeth and Cibac... The growth of premium has been actually six times the toothpaste category growth. It has accelerated to double the growth that we had last year. And if you remember on Jacob's slide, actually, the contribution has increased by 35% over the two-year period.

Provides a clear definition of the premium segment and quantifies its rapid growth and increasing contribution to the business, despite not disclosing its exact percentage of current sales.

Asked by Percy Panthaki

Sustainability of sales growth acceleration (base effect vs. structural change) Direct
We are feeling optimistic about the growth that we are seeing in our business. There are two or three key fundamentals that we believe have changed as we take a look at it. The first one is the performance of our core brand... Max Fresh continues to be exceptionally strong... Our premium brands are really responding to the inputs that have been given to those premium brands in terms of the amount of money on media and the way that that media has been deployed...

Management attributes the sales acceleration to fundamental shifts in core brand performance and effective premium brand investments, suggesting it's not merely a base effect.

Asked by Percy Panthaki

Impact of inverted duty structure on margins and potential offsets Direct
So, when the GST change happened, we passed through the entire gross saving, which is about 11%. So, the bulk of our products, GST rates moved from 18% to 5%, we didn't pass it on netting off the IDS... One is there are ways to be more efficient here... And then we are also making representation to the government... And the third piece is some of our key suppliers are also representing to the government to lower the rate... multiple ways we are looking at it. We stay optimistic that we will find a more reasonable solution to this.

Explains the financial impact of the inverted duty structure (80bps FY, 160bps Q4) and outlines multiple strategies being pursued to mitigate this ongoing challenge.

Asked by Harit Kapoor

Contribution of grammage increases to Q4 volume growth and overall volume outlook Direct
As Jacob mentioned, Latika, we have put through some grammage increases as part of the change in GST and passing on benefits to consumers. And actually, we have put through more than 11% on a few of the packs. However, given the pipelines of all of these, this is not the reason for the balanced volume and price growth. That's not the underlying reason... only about 30-40% of those SKUs, which are already just a small part of our business, are with higher grammage. So, we are not seeing that as the reason for the volume growth...

Clarifies that while grammage increases occurred, they were not the primary driver of Q4 volume growth, indicating underlying demand strength rather than just pack changes.

Asked by Latika Chopra

3 min read 8 chapters

Detailed narrative

Q4 Performance & Full Year Overview

Colgate-Palmolive (India) Limited delivered a strong Q4 FY26, with net sales growing 9% year-on-year to ₹1,583 crores and domestic growth at 9.2%. Gross margins remained robust at 69.6%, and EBITDA margins were best-in-class at over 32%. Q4 NPAT stood at ₹353 crores. For the full year FY26, the company reported flat top-line growth at ₹5,984 crores, with gross margins at 69.3% and EBITDA margins at 31.2%, which included an 80 basis points impact from the GST IDS.

Strategic Pillars & Consumption Driving Initiatives

The company's strategy revolves around driving consumption, accelerating premiumization, leading in toothbrushes, and growing personal care. Key initiatives include the 'Bright Smiles, Bright Future' program, which reached over 1 crore children in 2025, and partnerships with the government and dental professionals. A new 'Free Dental Checkup' program, accessible via QR codes on 500 million packs, has already seen close to 1 million people avail the service, aiming to increase proactive oral health engagement.

Core Brand Strength & Innovation

Colgate continues to strengthen its core brands. The relaunched Colgate Strong Teeth, with its advanced formulation, is 8.5 times more effective at re-mineralizing than competition. Colgate Max Fresh remains the fastest-growing franchise, driven by its superior product and unique cooling crystals. The company is also introducing future-forward innovations like 'Kids Squeezy' and a 'Harry Potter' range, along with extensions to the Max Fresh Sensorials range.

Accelerated Premiumization Strategy

Oral Care Premiumization is a significant growth driver, with the segment growing six times faster than the overall toothpaste category and its contribution increasing by 35% over the last two years. Key premium brands include Colgate Total, which leverages 'Dual Zinc and Arginine' technology, and Colgate Visible White Purple, which has seen stupendous success and is growing four times faster than the overall toothpaste category. The therapeutic portfolio, led by PerioGard, is doubling year-on-year, addressing gum problems and gaining recognition from the Indian Society of Periodontology.

Toothbrush & Personal Care Growth

The company sees significant growth opportunities in the toothbrush category, playing across value, mid-tier, and premium segments. New premium ranges for Colgate Total, PerioGuard, and Visible White have been launched, alongside entry-level ₹10 brushes. In Personal Care, the Palmolive brand focuses on Hand Wash and Body Wash, with the 'Moments Range' innovation and plans for a more digital-first approach to reach consumers.

Operational Excellence & Digital Transformation

Colgate-Palmolive emphasizes product and packaging superiority, with all formulations now considered 100% superior to competition. Distribution reach has expanded to 1.7 million outlets, adding 2 lakh stores in 2025. E-commerce, now approximately 10% of the business, is growth-accretive, margin-accretive, and share-accretive. The company is widely adopting AI for enhanced efficiency, forecasting, revenue growth management, and faster time-to-market for innovations.

Financial Health & Capital Allocation

The company maintains a strong financial position with cash-in of ₹1,806 crores and an impressive 121% return on capital employed. A second interim dividend of ₹48 per share was declared, aligning with a strategy to pay out virtually 100% of NPAT. Management expects gross margins to remain in range, while EBITDA margins are guided to be around 30-32% for the next two quarters, calibrated with advertising investments.

Market Dynamics & Challenges

The market is seeing a convergence of urban and rural growth, with urban markets picking up and rural growth slightly slowing. While the overall market is flat-to-increasing, the company faces headwinds from commodity and currency inflation, which are expected to persist for the next two quarters. The inverted duty structure (GST IDS) had an 80bps impact on full-year EBITDA and 160bps on Q4, with management actively pursuing solutions through efficiency and government representations. Promotional intensity in the market remains high.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Fast Moving Consumer Goods earnings calls